Literature DB >> 3277884

Biology of interleukin 1.

C A Dinarello1.   

Abstract

Interleukin 1 (IL 1) is a polypeptide that is produced after infection, injury, or antigenic challenge. Although the macrophage is a primary source of IL 1, epidermal, epithelial, lymphoid, and vascular tissues synthesize IL 1. When IL 1 gains access to the circulation, it acts like a hormone and induces a broad spectrum of systemic changes in neurological, metabolic, hematologic, and endocrinologic systems. Some of the IL 1 that is synthesized remains associated with the plasma membrane and induces changes in local tissues without producing systemic responses. IL 1 affects mesenchymal tissue remodeling where it contributes to both destructive and repair processes. IL 1 activates lymphocytes and plays an important role in the initiation of the immune response. Receptors for IL 1 have been identified, but receptors are scarce and their affinities often do not match the potency of the biological response. The most consistent property of IL 1 is up-regulation of cellular metabolism and increased expression of several genes coding for biologically active molecules. IL 1 is a highly inflammatory molecule and stimulates the production of arachidonic acid metabolites. IL 1 also acts synergistically with other cytokines, particularly tumor necrosis factor. The multitude of biological responses to IL 1 is an example of the rapid adaptive changes that take place to increase the host's defensive mechanisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3277884

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  248 in total

1.  Nerve growth factor induces growth and differentiation of human B lymphocytes.

Authors:  U Otten; P Ehrhard; R Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Activation of human monocytes/macrophages by hypo-osmotic shock.

Authors:  O Frenkel; E Shani; I Ben-Bassat; F Brok-Simoni; E Shinar; D Danon
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

3.  Expression of intrinsic factor in rat and murine gastric mucosal cell lineages is modified by inflammation.

Authors:  J Shao; R B Sartor; E Dial; L M Lichtenberger; W Schepp; D H Alpers
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Prevention of death of axotomized hypoglossal neurones and promotion of regeneration by chitin grafting.

Authors:  M Itoh; S Izumi; M Uemura; N Baba; K Suyama; Y Kuga; A Mizuno; P K Nakane; T Koji
Journal:  Cell Mol Neurobiol       Date:  2000-10       Impact factor: 5.046

5.  The release of interleukin-1-like activity by macrophages in two models of immunological inflammation in the rat.

Authors:  C Becherucci; D Donati; M Perretti; L Parente
Journal:  Agents Actions       Date:  1989-11

6.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels.

Authors:  A Schweizer; U Feige; A Fontana; K Müller; C A Dinarello
Journal:  Agents Actions       Date:  1988-12

8.  Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells.

Authors:  A Anisowicz; D Zajchowski; G Stenman; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  The effect of adrenalectomy on interleukin-1 release in vitro and in vivo.

Authors:  M Perretti; C Becherucci; G Scapigliati; L Parente
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

10.  Brain regions involved in the development of acute phase responses accompanying fever in rabbits.

Authors:  A Morimoto; N Murakami; T Nakamori; Y Sakata; T Watanabe
Journal:  J Physiol       Date:  1989-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.